Atherosclerosis
Volume 205, Issue 1 , Pages 284-289 , July 2009

High apoB/apoA-I ratio is associated with increased progression rate of carotid artery intima-media thickness in clinically healthy 58-year-old men: Experiences from very long-term follow-up in the AIR study

Received 5 June 2008 ,Revised 17 November 2008 ,Accepted 19 November 2008.

References 

  1. Bots ML, Hoes A, Koudstaal P, et al. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation. 1997;96:1432–1437
  2. O’Leary DH, Polak JF, Kronmal RA, et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med. 1999;340:14–22
  3. Weber F. Risk factors for subclinical carotid atherosclerosis in healthy men. Neurology. 2002;59:524–528
  4. Baldassare D, Amato M, Bondioli A, et al. Carotid artery intima-media thickness measured by ultrasonography in normal clinical practice correlates well with atherosclerosis risk factors. Stroke. 2000;31:2426–2430
  5. Hodis HN, Mack WJ, Dunn M, et al. Intermediate-density lipoproteins and progression of carotid arterial wall intima-media thickness. Circulation. 1997;95:2022–2026
  6. Salonen JT, Salonen R. Ultrasound B-mode imaging in observational studies of atherosclerotic progression. Circulation. 1993;87(3 Suppl.):II56–65
  7. Wallenfeldt K, Bokemark L, Wikstrand J, et al. Apolipoprotein B/apolipoprotein A-I in relation to the metabolic syndrome and change in carotid artery intima-media thickness during 3 years in middle-aged men. Stroke. 2004;35:2248–2252
  8. Walldius G, Jungner I. Is there a better marker of cardiovascular risk than LDL cholesterol? Apolipoproteins B and A-I—new risk factors and targets for therapy. Nutr Met Cardiovasc Dis. 2007;17:565–571
  9. Walldius G, Jungner I, Aastveit AH, et al. The apoB/apoA-I is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk. Clin Chem Lab Med. 2004;42:1355–1363
  10. Srivastava R, Srivastava N. High density lipoprotein, apolipoprotein A-I, and coronary artery disease. Mol Cell Biochem. 2000;209:131–144
  11. Jeng J-S, Sacco R, Kargman D, et al. Apolipoproteins and carotid artery atherosclerosis in an elderly multiethnic population: the Northern Manhattan Stroke study. Atherosclerosis. 2002;165:317–325
  12. Bokemark L, Frödén A, Attvall S, et al. The euglycemic clamp examination: variability and reproducibility. Scand J Clin Lab Invest. 2000;60:27–36
  13. Wallenfeldt K, Hulthe J, Bokemark L, et al. Carotid and femoral atherosclerosis, cardiovascular risk factors and C-reactive protein in relation to smokeless tobacco use or smoking in 58-year-old men. J Int Med. 2001;250:492–501
  14. Schmidt C, Fagerberg B, Hulthe J. Non-stenotic echolucent ultrasound-assessed femoral artery plaques are predictive for future cardiovascular events in middle-aged men. Atherosclerosis. 2005;181:125–130
  15. Schmidt C, Fagerberg B, Hulthe J. 58-year old men with non-stenotic carotid artery plaques and the relationship with cardiovascular risk factors and future cardiovascular events. Vasc Dis Prev. 2005;2:129–134
  16. Tivesten Å, Hulthe J, Wallenfeldt K, et al. Circulating estradiol is an independent predictor of progression of carotid artery intima-media thickness in middle-aged men. Clin Endocrinol Metab. 2006;91:4433–4437
  17. Bokemark L, Wikstrand J, Wedel H, et al. Insulin, insulin propeptides and intima-media thickness in the carotid artery in 58-year-old clinically healthy men. The Atherosclerosis and Insulin Resistance study (AIR). Diabetic Med. 2002;19:144–151
  18. Hulthe J, Wiklund O, Olsson G, et al. Computerized measurement of LDL particle size in human serum. Scand J Clin Lab Invest. 1999;59:649–662
  19. Wendelhag I, Liang Q, Gustavsson T, et al. A new automated computerized analyzing system simplifies readings and reduces the variability in ultrasound measurements of intima-media thickness. Stroke. 1997;28:2195–2200
  20. Schmidt C, Wendelhag I. How can the variability in ultrasound measurement of intima-media thickness be reduced? Studies of interobserver variability in carotid and femoral arteries. Clin Phys. 1999;19:45–55
  21. Baldassare D, Amato M, Bondioli A, et al. Carotid artery intima-media thickness (IMT) measured by ultrasonography in normal clinical practice correlates well with atherosclerosis risk factors. Stroke. 2000;31:2426–2430
  22. Walldius G, Jungner I. Rationale for using apolipoprotein B and apolipoprotein A-I as indicators of cardiac risk and as targets for lipid-lowering therapy. Eur Heart J. 2005;26:210–212
  23. Schmidt C, Fagerberg B. ApoB/apoA-I ratio is related to femoral artery plaques in 64-year-old women also in cases with low LDL cholesterol. Atherosclerosis. 2008;196:817–822
  24. Jadhav UM, Kadam NN. Apolipoproteins: correlation with carotid intima media thickness and coronary artery disease. J Assoc Physician India. 2004;52:370–375
  25. Williams K, Sniderman AD, Sattar N, et al. Comparison of the association of apolipoprotein B and low-density lipoprotein cholesterol with other cardiovascular risk factors in the Insulin Resistance Atherosclerosis Study (IRAS). Circulation. 2003;108:2312–2316
  26. Walldius G, Jungner I, Holme I, et al. High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet. 2001;358:2026–2033
  27. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case–control study. Lancet. 2004;364:937–952
  28. Paraskevas KI, Hamilton G, Mikahilidis DP. Statins: an essential component in the management of carotid artery disease. J Vasc Surg. 2007;46:373–386
  29. Crouse JR, Raichlen JS, Riley WA, et al. Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis. The METEOR Trial. JAMA. 2007;297:1344–1353
  30. Walldius G, Jungner I. Apolipoprotein B and apolipoprotein A-I: risk indicators of coronary heart disease and targets of lipid-modifying therapy. J Int Med. 2004;255:188–205

PII: S0021-9150(08)00819-8

doi: 10.1016/j.atherosclerosis.2008.11.025

Atherosclerosis
Volume 205, Issue 1 , Pages 284-289 , July 2009

Article Tools

* Image Usage & Resolution